-
After a yearlong investigation, the National Transportation Safety Board did not find a single cause for the deadly collision near Washington, D.C., but blamed the crash on multiple systemic failures.
-
Three Texas siblings who died in an icy pond are among several dozen deaths in U.S. states gripped by frigid cold. A massive storm dumped deep snow across more than 1,300 miles from Arkansas to New England.
-
A sharp drop in net immigration has led to a slowdown in U.S. population growth. The Census Bureau says the population grew only about half as fast in the year ending last June as it did the previous year.
-
The best books for children and young adults were awarded the country's top honors by the American Library Association on Monday.
-
Writer Jason Zengerle says Carlson had the foresight to see Trump's potential in 2015. Now he's someone the president "definitely listens to." Zengerle's new book is Hated by All the Right People.
-
Researchers discovered a feedback loop between nerve cells, the immune system and the heart. They think it shows promise as a target for future therapies.
-
The case filed in Massachusetts is the first lawsuit over the strikes to land in a U.S. federal court since the Trump administration launched a campaign to target vessels off the coast of Venezuela.
-
It's never been easier to bet on sports. And polls show the majority of American men are involved in sports betting. To learn more, we want to hear from you about your betting experiences.
-
Jonathan Haidt's 2024 book made the case that screen time had "rewired" kids' brains. The Amazing Generation is a collab with science journalist Catherine Price and graphic novelist Cynthia Yuan Cheng.
-
India and the European Union have reached a free trade agreement, at a time when Washington targets them both with steep import tariffs, pushing major economies to seek alternate partnerships.
-
CBS News Editor-in-Chief Bari Weiss came in with a mandate to reshape coverage. She laid out her strategy in a staff meeting Tuesday.
-
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of obesity. They foresee a future of personalized obesity medicine similar to the way cancer is treated now.